J Gynecol Oncol.  2017 Mar;28(2):e9. 10.3802/jgo.2017.28.e9.

Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7

Affiliations
  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • 2Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea. gynlim@gmail.com
  • 3Department of Statistics, Dongguk University School of Medicine, Seoul, Korea.
  • 4Bio Medical Laboratory Science, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • 5Biometric Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • 6Rehabilitation Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • 7Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Abstract


OBJECTIVE
The Gynecologic Cancer Lymphedema Questionnaire (GCLQ) was designed to identify gynecologic cancer patients with lower limb lymphedema (LLL). The questionnaire consists of 20 items distributed over 7 symptom clusters. The present study aimed to develop an abridged form of the GCLQ for simpler screening and more effective follow-up of LLL.
METHODS
Data that had been collected for the development and validation of the Korean version of the GCLQ (GCLQ-K) were used in this study. Receiver-operating characteristic (ROC) curves were drawn according to the individual items of the GCLQ-K. Based on discrimination ability, the candidate items were selected in each symptom cluster. After combining the items, the best model was identified and named GCLQ-7. The area under the ROC curve (AUC) was compared between the GCLQ-7 and the original GCLQ-K.
RESULTS
In total, 11 candidate items were selected from the original GCLQ-K. Among the models made with the candidate items, GCLQ-7, the best model, was constructed with 7 items as follows: 1) limited knee movement, 2) general swelling, 3) redness, 4) firmness/tightness, 5) groin swelling, 6) heaviness, and 7) aching. This model exhibited an AUC of 0.945 (95% confidence interval [CI], 0.900-0.991), which is comparable with that of the original GCLQ-K (AUC, 0.867; 95% CI, 0.779-0.956). The best cutoff value was 2 points, at which the sensitivity and specificity were 97.0% and 76.5%, respectively.
CONCLUSION
The newly developed short version model, GCLQ-7, showed acceptable discrimination ability as compared with the original GCLQ-K.

Keyword

Genital Neoplasms, Female; Uterine Cervical Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms; Lymphedema; Surveys and Questionnaires

MeSH Terms

Female
Genital Neoplasms, Female/*complications
Humans
*Lower Extremity
Lymphedema/*etiology
Quality of Life
ROC Curve
Republic of Korea
Retrospective Studies
Sensitivity and Specificity
*Surveys and Questionnaires
Translating
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr